The changes of hepatic bile acid synthesis and transport and bile acids profiles in isopsoralen-induced liver injury C57BL/6J mice

References

• Alam F, Khan GN, Asad M. 2018. Psoralea corylifolia L: ethnobotanical, biological, and chemical aspects: a review. Phytother Res. 32(4):597–615.
   PubMed Web of Science ®Google Scholar
• Alrefai WA, Gill RK. 2007. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res. 24(10):1803–1823.
   PubMed Web of Science ®Google Scholar
• Anderson FH, Zeng L, Rock NR, Yoshida EM. 2000. An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatol Res. 18(1):63–71.
   PubMed Web of Science ®Google Scholar
• Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. 1986. Bile acid-induced liver toxicity: relation to the hydrophobic–hydrophilic balance of bile acids. Med Hypotheses. 19(1):57–69.
   PubMed Web of Science ®Google Scholar
• Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, Holm H, Sanna S, Kavousi M, Baumeister SE, et al. 2011. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet. 43(11):1131–1138.
   PubMed Web of Science ®Google Scholar
• Cheung WI, Tse ML, Ngan T, Lin J, Lee WK, Poon WT, Mak TW, Leung VK, Chau TN. 2009. Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine. Clin Toxicol. 47(7):683–685.
   PubMed Web of Science ®Google Scholar
• Chiang JY. 2009. Bile acids: regulation of synthesis. J Lipid Res. 50(10):1955–1966.
   PubMed Web of Science ®Google Scholar
• Chiang JY. 2013. Bile acid metabolism and signaling. Compr Physiol. 3(3):1191–1212.
   PubMed Web of Science ®Google Scholar
• Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R, Lammert F, Stieger B, Meier PJ, Zatloukal K, et al. 2001. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology. 121(1):170–183.
   PubMed Web of Science ®Google Scholar
• García-Cañaveras JC, Donato MT, Castell JV, Lahoz A. 2012. Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method. J Lipid Res. 53(10):2231–2241.
   PubMed Web of Science ®Google Scholar
• Ge L, Cui Y, Cheng K, Han J. 2018. Isopsoralen enhanced osteogenesis by targeting AhR/ERα. Molecules. 23(10):2600.
   PubMed Web of Science ®Google Scholar
• Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, Celle G, Testa R. 1999. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci. 44(6):1249–1253.
   PubMed Web of Science ®Google Scholar
• Heuman DM. 1989. Quantitative estimation of the hydrophilic–hydrophobic balance of mixed bile salt solutions. J Lipid Res. 30(5):719–730.
   PubMed Web of Science ®Google Scholar
• Jetter A, Kullak-Ublick GA. 2020. Drugs and hepatic transporters: a review. Pharmacol Res. 154:104234.
   PubMed Web of Science ®Google Scholar
• Kong LD, Tan RX, Woo AY, Cheng CH. 2001. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacol Toxicol. 88(2):75–80.
   PubMedGoogle Scholar
• Koul B, Taak P, Kumar A, Kumar A, Sanyal I. 2019. Genus Psoralea: a review of the traditional and modern uses, phytochemistry and pharmacology. J Ethnopharmacol. 232:201–226.
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Stieger B, Meier PJ. 2004. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology. 126(1):322–342.
   PubMed Web of Science ®Google Scholar
• Kurdi P, Kawanishi K, Mizutani K, Yokota A. 2006. Mechanism of growth inhibition by free bile acids in Lactobacilli and Bifidobacteria. J Bacteriol. 188(5):1979–1986.
   PubMed Web of Science ®Google Scholar
• Latha PG, Evans DA, Panikkar KR, Jayavardhanan KK. 2000. Immunomodulatory and antitumour properties of Psoralea corylifolia seeds. Fitoterapia. 71(3):223–231.
   PubMed Web of Science ®Google Scholar
• Li M, Cai SY, Boyer JL. 2017. Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 56:45–53.
   PubMed Web of Science ®Google Scholar
• Li XM, Yang Q, Li XB, Cheng Q, Zhang K, Han J, Zhao JN, Liu G, Zhao MG. 2017. Estrogen-like neuroprotection of isopsoralen against spinal cord injury through estrogen receptor ERα. Metab Brain Dis. 32(1):259–265.
   PubMed Web of Science ®Google Scholar
• Lu YT. 1983. Observations on effect of Fructus Psoraleae injection in 800 cases of psoriasis. J Tradit Chin Med. 3(3):229–230.
   PubMedGoogle Scholar
• Morita SY, Ikeda Y, Tsuji T, Terada T. 2019. Molecular mechanisms for protection of hepatocytes against bile salt cytotoxicity. Chem Pharm Bull. 67(4):333–340.
   PubMed Web of Science ®Google Scholar
• Nam SW, Baek JT, Lee DS, Kang SB, Ahn BM, Chung KW. 2005. A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee). Clin Toxicol. 43(6):589–591.
   PubMed Web of Science ®Google Scholar
• Okubo S, Miyamoto M, Ito D, Takami K, Ashida K. 2016. Albumin and apolipoprotein H mRNAs in human plasma as potential clinical biomarkers of liver injury: analyses of plasma liver-specific mRNAs in patients with liver injury. Biomarkers. 21(4):353–362.
   PubMed Web of Science ®Google Scholar
• Penndorf V, Saner F, Gerken G, Canbay A. 2013. Liver parameters in intensive care medicine. Zentralbl Chir. 138:636–642.
   PubMed Web of Science ®Google Scholar
• Perez MJ, Briz O. 2009. Bile-acid-induced cell injury and protection. World J Gastroenterol. 15(14):1677–1689.
   PubMed Web of Science ®Google Scholar
• Piñeiro-Carrero VM, Piñeiro EO. 2004. Liver. Pediatrics. 113(4 Suppl.):1097–1106.
   PubMed Web of Science ®Google Scholar
• Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM. 2000. Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy. Toxicol Sci. 57(1):177–185.
   PubMed Web of Science ®Google Scholar
• Sagawa H, Tazuma S, Kajiyama G. 1993. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am J Physiol. 264(5 Pt 1):G835–G839.
   PubMedGoogle Scholar
• Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17(2):225–235.
   PubMed Web of Science ®Google Scholar
• Stacey M, Webb M. 1947. Studies on the antibacterial properties of the bile acids and some compounds derived from cholanic acid. Proc R Soc Med. 134(877):523–537.
   PubMedGoogle Scholar
• Trauner M, Boyer JL. 2003. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev. 83(2):633–671.
   PubMed Web of Science ®Google Scholar
• Trauner M, Meier PJ, Boyer JL. 1998. Molecular pathogenesis of cholestasis. N Engl J Med. 339(17):1217–1227.
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang Z, Ji J, Li Y, Chen M, Wang Y, Zhang Y, Tai T, Wang T, Zhang L. 2012. Evaluation of hepatotoxicity and cholestasis in rats treated with EtOH extract of Fructus Psoraleae. J Ethnopharmacol. 144(1):73–81.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang H, Jiang JM, Zheng D, Chen YY, Wan SJ, Tan HS, Tang LM, Xu HX. 2019. Hepatotoxicity induced by psoralen and isopsoralen from Fructus Psoraleae: Wistar rats are more vulnerable than ICR mice. Food Chem Toxicol. 125:133–140.
   PubMed Web of Science ®Google Scholar
• Xiao G, Li G, Chen L, Zhang Z, Yin JJ, Wu T, Cheng Z, Wei X, Wang Z. 2010. Isolation of antioxidants from Psoralea corylifolia fruits using high-speed counter-current chromatography guided by thin layer chromatography-antioxidant autographic assay. J Chromatogr A. 1217(34):5470–5476.
   PubMed Web of Science ®Google Scholar
• Xin D, Wang H, Yang J, Su YF, Fan GW, Wang YF, Zhu Y, Gao XM. 2010. Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomedicine. 17(2):126–131.
   PubMed Web of Science ®Google Scholar
• Yang T, Shu T, Liu G, Mei H, Zhu X, Huang X, Zhang L, Jiang Z. 2017. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids. J Steroid Biochem Mol Biol. 172:69–78.
   PubMed Web of Science ®Google Scholar
• Zhang P, Ye Y, Yang X, Jiao Y. 2016. Systematic review on Chinese herbal medicine induced liver injury. Evid Based Complement Alternat Med. 2016:3560812.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yuan XM, Wang YF, Jiang MM, Bi YN, Liu Y, Pu WL, Song L, Huang JY, Sun LK, et al. 2019. Isopsoralen induces different subchronic toxicities and metabolomic outcomes between male and female Wistar rats. Regul Toxicol Pharmacol. 103:1–9.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Li J, Chen Y, Han L, He Q, Chu J, Liu K. 2019. The role of hepatic antioxidant capacity and hepatobiliary transporter in liver injury induced by isopsoralen in zebrafish larvae. Hum Exp Toxicol. 38(1):36–44.
   PubMed Web of Science ®Google Scholar
• Zollner G, Fickert P, Fuchsbichler A, Silbert D, Wagner M, Arbeiter S, Gonzalez FJ, Marschall HU, Zatloukal K, Denk H, et al. 2003. Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol. 39(4):480–488.
   PubMed Web of Science ®Google Scholar
• Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, et al. 2001. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology. 33(3):633–646.
   PubMed Web of Science ®Google Scholar